Second-most common breast cancer subtype may benefit from personalized treatment approach

(University of Pittsburgh Schools of the Health Sciences) The second-most common type of breast cancer is a very different disease than the most common and appears to be a good candidate for a personalized approach to treatment. Invasive lobular carcinoma, characterized by a unique growth pattern in breast tissue that fails to form a lump, has distinct genetic markers that indicate there may be benefits from drug therapies beyond those typically prescribed for the more common invasive ductal carcinoma.
Source: EurekAlert! - Biology - Category: Biology Source Type: news